Phase I Study of MT1011 Injection in Healthy Subjects
Phase I Study of MT1011 Injection in Healthy Subjects
Recruiting · NCT07024160 · Registry updated 2025-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of MT1011 Injection in Healthy Subjects | Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation | Recruiting | Phase 1 | 2025-07-03 | NCT07024160 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Shijitan Hospital, Capital Medical University | Beijing | China | 6 |